Skip to main content
letter
. 2022 May 25;24(8):1656–1660. doi: 10.1111/dom.14730

TABLE 1.

Characteristics of study participants with and without cholecystectomy

Total (n = 1612) Without cholecystectomy (n = 1564) With cholecystectomy (n = 48) P
Years since cholecystectomy NA 11.2 ± 7.1
Female, n (%) 1031 (64.0) 995 (63.6) 36 (75.0) 0.11
Age, years 52.3 ± 9.1 52.1 ± 9.2 56.1 ± 6.3 <0.001
Current smoking, n (%) 264 (16.4) 260 (16.6) 4 (8.3) 0.13
Current drinking, n (%) 397 (24.6) 386 (24.7) 11 (22.9) 0.78
BMI, kg/m2 25.3 ± 3.5 25.3 ± 3.5 25.7 ± 3.2 0.47
Waist circumference, cm 85.3 ± 9.4 85.2 ± 9.4 86.2 ± 8.9 0.49
SBP, mmHg 132.9 ± 18.9 132.8 ± 18.9 137.2 ± 18.5 0.12
DBP, mmHg 81.2 ± 11.4 81.2 ± 11.4 81.2 ± 12.0 0.97
FPG, mmol/L 5.9 ± 1.1 5.9 ± 1.1 6.2 ± 1.1 0.06
2hPG, mmol/L a 7.4 ± 2.5 7.4 ± 2.4 8.2 ± 2.7 0.03
HbA1c, % (mmol/mol) 5.5 ± 0.8 (36.6 ± 8.4) 5.5 ± 0.8 (36.6 ± 8.4) 5.6 ± 0.8 (37.3 ± 8.9) 0.5
TyG 8.8 ± 0.7 8.8 ± 0.7 8.7 ± 0.7 0.74
SPISE 6.7 ± 1.8 6.7 ± 1.8 6.5 ± 1.9 0.39
TC, mmol/L 4.9 ± 0.9 4.9 ± 0.9 4.9 ± 0.9 0.68
TG, mmol/L 1.3 (0.9, 1.9) 1.3 (0.9, 1.9) 1.4 (0.9, 2.1) 0.67
HDL, mmol/L 1.5 ± 0.4 1.5 ± 0.4 1.5 ± 0.4 0.93
LDL, mmol/L 2.7 ± 0.7 2.7 ± 0.7 2.7 ± 0.6 0.67
BUN, mmol/L 5.3 ± 1.4 5.3 ± 1.4 5.5 ± 1.5 0.28
Cr, umol/L 64.7 ± 15.7 64.7 ± 15.7 65.6 ± 15.3 0.69
Glycaemic status, n (%) <0.001
Normoglycaemia 899 (55.8) 887 (56.7) 12 (25.0) <0.001
Prediabetes 544 (33.7) 520 (33.2) 24 (50.0) 0.02
Diabetes 169 (10.5) 157 (10.0) 12 (25.0) 0.001
Glucose‐lowering therapies
Baseline, n (%) 52 (3.2) 49 (3.1) 3 (6.3) 0.20
Follow‐up, n (%) 54 (3.3) 52 (3.3) 2 (4.2) 0.67

Data are presented as means ± SD or median (25th percentile, 75th percentile) or number (%).

Unpaired Student's t‐test or Mann–Whitney U‐test for continuous data and chi‐squared test or Fisher's exact test for categorical data were used to compare parameters between two groups.

Abbreviations: BMI, body mass index; BUN, blood urea nitrogen; Cr, creatinine; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HbA1c, glycated haemoglobin; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; SBP, systolic blood pressure; SPISE, single‐point insulin sensitivity estimator; TC, total cholesterol; TG, triglycerides; TyG, triglyceride‐glucose index; 2hPG, 2‐hour plasma glucose.

a

2hPG was not measured in 54 participants at baseline due to previously confirmed diagnosis of diabetes (n = 49 in the subgroup without cholecystectomy, and n = 5 in the subgroup with cholecystectomy).